Our primary objective is to assess the safety of autologous fat grafting for women who have had operable primary breast cancer. The safety of autologous fat grafting can be divided into oncological safety and operation-related safety. Oncological safety will be evaluated mainly by local breast cancer recurrence rate. The operation-related safety will be measured mainly by post-operative morbidity.
Our secondary objective is the efficacy of autologous fat grafting. The efficacy of autologous fat grafting will be measured mainly by quality of life questionnaires and cost-utility analysis. Fees for fat grafting will be accumulated if more than one grafting is needed.
This is a protocol.